[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100543702":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":18,"locations":24,"responsibleParty":39,"collaborators":7,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":7,"eligibilityCriteria":47,"healthyVolunteers":43,"sex":48,"minAge":49,"maxAge":7,"enrollmentInfo":50,"targetDuration":7,"studyType":53,"phases":7,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":26,"whyStopped":7,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"Limacorporate S.p.a","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DEVICE","DELTA Revision acetabular cup","Total hip arthroplasty",[14],{"name":15,"affiliation":16,"role":17},"Jerzy Bialecki","Samodzielny Publiczny Szpital Kliniczny im. Prof. Adama Grucy CMKP","PRINCIPAL_INVESTIGATOR",[19],{"name":20,"role":21,"phone":22,"phoneExt":7,"email":23},"Federica Azzimonti","CONTACT","+39 377 5450940","federica.azzimonti@limacorporate.com",[25],{"facility":16,"status":26,"city":27,"state":7,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"RECRUITING","Otwock","05-400","Poland","PL",{"type":32,"coordinates":33},"Point",[34,35],21.26129,52.10577,{"lat":35,"lon":34},[38],{"name":15,"role":21,"phone":7,"phoneExt":7,"email":7},{"type":40,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100543702","h-34-delta-revision-cup-100543702",false,"NCT06359301","H-34 DELTA Revision Cup","An Open Label, Observational, Prospective, Longitudinal Cohort Study to Evaluate Safety, Clinical and Radiographic Outcomes of Total Hip Arthroplasty With DELTA Revision Cup","Inclusion Criteria:\n\n* male or female in whom a decision has already been made to perform a total hip arthroplasty with DELTA Revision acetabular cup as per indication for use. The decision to implant DELTA revision acetabular cup must be taken prior to, and independently from the decision to enroll the patient. This decision should be made in accorsance with routine clinical practice at the study site concerned.\n* Age ≥ 18 years old\n* All patients mist give written informed consent approved by the study site's Institutinal Review Board (IRB)\u002FEthical Committee (EC)\n* Patient is able to comply with the protocol\n\nExclusion Criteria:\n\n* Adult patients with any DELTA Revision acetabular cup contraindication for use as reported in the current local instruction for use.\n* For female patiens, current pregnancy and\u002For lactation or planning a pregnancy","ALL","18 Years",{"count":51,"type":52},49,"ESTIMATED","OBSERVATIONAL","THis study is aimed to provide a clinical and radiographic evaluation of 49 suitable subjects who underwent a total hip arthroplasty with DELTA Revision acetabular cup.",[56],"Hip, Osteoarthritis",[58],"revision","2026-01-20",{"date":61,"type":62},"2026-01-22","ACTUAL",{"date":64,"type":62},"2021-09-14",{"date":66,"type":52},"2028-12",{"name":5,"class":6},1]